Q32 Bio, Inc. (QTTB)
8.23
-0.02
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
8.24
+0.01
(+0.12%)
After-Hours: 20:00
Q32 Bio Max Drawdown (5Y) : 99.58% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.58% |
| August 31, 2026 | 99.58% |
| July 31, 2026 | 99.58% |
| June 30, 2026 | 99.58% |
| May 31, 2026 | 99.58% |
| April 30, 2026 | 99.58% |
| March 31, 2026 | 99.58% |
| February 28, 2026 | 99.58% |
| January 31, 2026 | 99.58% |
| December 31, 2025 | 99.58% |
| November 30, 2025 | 99.58% |
| October 31, 2025 | 99.58% |
| September 30, 2025 | 99.58% |
| August 31, 2025 | 99.58% |
| July 31, 2025 | 99.58% |
| June 30, 2025 | 99.58% |
| May 31, 2025 | 99.58% |
| April 30, 2025 | 99.58% |
| March 31, 2025 | 99.53% |
| February 28, 2025 | 99.44% |
| January 31, 2025 | 99.24% |
| December 31, 2024 | 99.22% |
| November 30, 2024 | 98.25% |
| October 31, 2024 | 98.25% |
| September 30, 2024 | 98.25% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.25% |
| July 31, 2024 | 98.25% |
| June 30, 2024 | 98.25% |
| May 31, 2024 | 98.25% |
| April 30, 2024 | 98.25% |
| March 31, 2024 | 98.25% |
| February 29, 2024 | 98.25% |
| January 31, 2024 | 98.25% |
| December 31, 2023 | 98.25% |
| November 30, 2023 | 98.25% |
| October 31, 2023 | 97.26% |
| September 30, 2023 | 97.26% |
| August 31, 2023 | 97.26% |
| July 31, 2023 | 97.26% |
| June 30, 2023 | 97.26% |
| May 31, 2023 | 97.00% |
| April 30, 2023 | 97.00% |
| March 31, 2023 | 97.00% |
| February 28, 2023 | 96.41% |
| January 31, 2023 | 96.41% |
| December 31, 2022 | 96.41% |
| November 30, 2022 | 95.58% |
| October 31, 2022 | 95.58% |
| September 30, 2022 | 95.42% |
| August 31, 2022 | 95.42% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Intellia Therapeutics, Inc. | 96.45% |
| Beam Therapeutics, Inc. | 89.12% |
| Prime Medicine, Inc. | -- |
| Prelude Therapeutics, Inc. | 99.33% |
| Twist Bioscience Corp. | 94.48% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -50.19 |
| Beta (5Y) | 0.3061 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 121.0% |
| Historical Sharpe Ratio (5Y) | -0.3894 |
| Historical Sortino (5Y) | -0.7743 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.94% |